Pen Needles Market

7500+ companies worldwide approach us every year for their revenue growth initiatives

Global top 2000 strategist rely on us for their growth strategies.

80% of fortune 2000 companies rely on our research to identify new revenue sources.

30000 High Growth Opportunities

95% renewal rate

KNOW MORE

Pen Needles Market by Type (Standard Pen & Safety Pen Needles), Length (4mm, 5mm, 6mm, 8mm, 10mm, 12mm), Therapy (Insulin, GLP 1, Growth Hormone), and Mode of Purchase, End User, Unmet Needs, Key Stakeholders, Buying Criteria - Global Forecast to 2028

FREE BROCHURE FREE SAMPLE REPORT

Report Code: MD 2851 Oct, 2023, by marketsandmarkets.com

The global pen needles market in terms of revenue was estimated to be worth $1.6 billion in 2023 and is poised to reach $2.5 billion by 2028, growing at a CAGR of 9.1% from 2023 to 2028. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.

Various factors such as the increasing shift of therapy to home settings, growing preference for biosimilar drugs, and emerging markets are likely to accelerate the growth of the market. Moreover, the presence of well-established key players focusing on improving the awareness regarding insulin delivery devices and their home use are likely to propel the market growth during the forecast period.

Attractive opportunities Pen Needles Market

Pen Needles Market

To know about the assumptions considered for the study, Request for Free Sample Report

Pen Needles Market

Pen Needles Market Dynamics

Driver: Growing adoption of self-administration

Due to the advantages that pen injectors offer over conventional drug administration methods using vials and syringes include ease of use, especially at home, which eliminates the need for frequent trips to clinics or healthcare facilities. Pen injectors also offer a low risk of errors while administering the correct dose. Pen injectors can reduce pain at the injection site, especially if used with shorter pen needles, and improve the quality of life compared to other drug delivery modes.

These advantages are expected to drive market growth during the forecast period.

Restraint: Preference for alternative modes of drug delivery

Some of the problems associated with using pen needles include needlestick injuries and infections, hyperglycemia, and pain. Due to inability to regulate the dosage, these are sometimes associated with hyperglycemia. Therefore, in some regions, insulin pumps are preferred over pens for administering insulin. This is one of the major restraints facing the pen needles market.

Opportunity: Emerging markets

Emerging markets such as those in China, India, Mexico, and Brazil are fast-growing pen needle markets. The growing prevalence of diabetes, the growing healthcare expenditure, and diabetes treatment awareness, growing per capita income, and increasing R&D initiatives to develop innovative medical technologies are some of the factors driving these regional markets. Not only that, from the supply side perspective, cheap labor and low-cost manufacturing are major advantages for key market players.

Challenge: Reuse of pen needles

Reuse of pen needles is a major challenge in the pen needles market. Although manufacturers’ instructions advise against it, reuse of pen needles varies across geographies from as low as 30% to a staggering 95% of patients reusing their needles. According to a study published in Value Health Journal, about 98.35% of patients reuse insulin pen needles in China. Reasons for this stem mostly from inability to afford regular purchases. Most developing countries don’t have insurance coverage for pen needles, which makes it even more difficult to use fresh pen needles for every injection.

Ecosystem Analysis

The ecosystem of the pen needles market comprises elements present in this market and defines these elements with a demonstration of the bodies involved. It includes manufacturers, distributors, research & product developers, and end users.

Pen Needles Market Ecosystem

By type, safety pen needles segment of the pen needles industry is expected to grow at the higher CAGR during the forecast period.

The largest share of the pen needles market by type is occupied by standard pen needles in 2022. This can be attributed to the lower cost, especially considering pen needles need to be bought regularly, and therefore, becomes a recurring cost. However, as standard needles are not equipped with safety shields, the risk of accidental needlestick injuries (NSIs) with these needles is high. Therefore, the demand for safety pen needles is expected to grow considerably in the coming years due to growing concerns regarding the prevention of NSIs, making it the segment with the higher CAGR.

The insulin therapy is witnessed to have highest growth rate of the pen needles industry, by application during the forecast period.

In the pen needles market, the GLP-1 therapy segment is expected to grow at the fastest rate after insulin therapy during the forecast period. The high growth rate of the GLP-1 therapy segment can be attributed to the rapidly rising incidence of type 2 diabetes, and the increasing patient awareness on newer therapies and injectables to manage diseases.

Other modes of purchase segment accounted for the largest share of the pen needles industry, after over-the-counter purchase, by mode of purchase, in 2022

The other modes of purchase segment includes insurance coverage, patient assistance programs, and private/government financial aid programs. This segment accounted for the second largest share of the pen needles market by mode of purchase. This can be chalked down mostly to the increasing insurance cover for diabetes and other chronic disease related medication and products, especially in developed countries like the US.

Pen Needles Market by Region

To know about the assumptions considered for the study, download the pdf brochure

North America is projected to be the largest regional market for pen needles industry

North America dominates the pen needles market. The North American region is gaining traction with the increasing incidence and prevalence of chronic diseases. Moreover due to strong foothold of major key players in the region, rising approval of pen injectors for multiple applications across many countries, and initiatives by government to increase the awareness about the advancements in insulin drug delivery are likely to play a major role in fueling the growth of the pen needles market in North America.

The prominent players operating in the global market include Ypsomed Holding AG (Switzerland), Embecta Corp. (US), B. Braun Melsungen AG (Germany), and Novo Nordisk (Denmark).

Scope of the Pen Needles Industry:

Report Metric	Details
Market Revenue in 2023	$1.6 billion
Estimated Value by 2028	$2.5 billion
Revenue Rate	Poised to grow at a CAGR of 9.1%
Market Driver	Growing adoption of self-administration
Market Opportunity	Emerging Markets

This research report categorizes the pen needles market to forecast revenue and analyze trends in each of the following submarkets:

By Type

Standard Pen Needles
Safety Pen Needles

By Length

4mm
5mm
6mm
8mm
10mm
12mm

By Application

Insulin Therapy
GLP-1 Therapy
Growth Hormone Therapy
Osteoporosis
Other Applications

By Mode of Purchase

Prescription-based
Over the Counter
Online Purchase
Other Modes of Purchase

By Setting

Homecare
Hospitals & Clinics
Other settings

By Region

North America
- US
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- RoE
Asia Pacific
- Japan
- China
- India
- Australia
- South Korea
- Southeast Asia
- RoAPAC
Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
Middle East and Africa

Recent Developments of Pen Needles Industry

In February 2023, Montmed, Inc. (Canada) announced issuance of a second US Patent for Sitesmart Pen Needles.
In April 2022, Embecta Corp. (US) completed the spin-off from Becton, Dickinson and Company (US) and started operating globally as a standalone pure-play diabetes care company.
In February 2021, UltiMed, Inc. (US) launched UltiCare safety pen needles in two sizes, 5mm 30G and 8mm 30 G.
In January 2021, NHS (UK) chose Owen Mumford (UK) as the sole supplier of safety pen needles. With this partnership, Owen’s pen needles will be used in all NHS Wales hospitals.

Frequently Asked Questions (FAQ):

What is the projected market revenue value of the global pen needles market?

The global pen needles market boasts a total revenue value of $2.5 billion by 2028.

What is the estimated growth rate (CAGR) of the global pen needles market?

The global pen needles market has an estimated compound annual growth rate (CAGR) of 9.1% and a revenue size in the region of $1.6 billion in 2023.

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS

1 INTRODUCTION (Page No. - 23)

1.1 STUDY OBJECTIVES

1.2 MARKET DEFINITION

1.2.1 INCLUSIONS AND EXCLUSIONS

1.2.2 MARKET SEGMENTATION

1.2.3 YEARS CONSIDERED

1.3 CURRENCY CONSIDERED

TABLE 1 STANDARD CURRENCY CONVERSION RATES

1.4 LIMITATIONS

1.5 STAKEHOLDERS

1.6 SUMMARY OF CHANGES

1.7 RECESSION IMPACT

2 RESEARCH METHODOLOGY (Page No. - 29)

2.1 RESEARCH DATA

FIGURE 1 RESEARCH DESIGN

2.1.1 SECONDARY DATA

2.1.1.1 Key data from secondary sources

2.1.2 PRIMARY DATA

FIGURE 2 PRIMARY SOURCES

2.1.2.1 Key data from primary sources

2.1.2.2 Key industry insights

FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION

FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY SETTING AND REGION

FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS

2.2 MARKET SIZE ESTIMATION

FIGURE 6 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS

FIGURE 7 REVENUE SHARE ANALYSIS ILLUSTRATION: EMBECTA CORP. (2022)

FIGURE 8 REVENUE ANALYSIS OF TOP FIVE COMPANIES: PEN NEEDLES MARKET (2022)

FIGURE 9 DEMAND-SIDE ANALYSIS

FIGURE 10 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2023–2028)

FIGURE 11 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS

FIGURE 12 TOP-DOWN APPROACH

2.3 MARKET BREAKDOWN AND DATA TRIANGULATION

FIGURE 13 DATA TRIANGULATION METHODOLOGY

2.4 MARKET SHARE ANALYSIS

2.5 STUDY ASSUMPTIONS

2.6 RISK ASSESSMENT

TABLE 2 RISK ASSESSMENT ANALYSIS

2.7 METHODOLOGY-RELATED LIMITATIONS

2.8 RECESSION IMPACT ANALYSIS

3 EXECUTIVE SUMMARY (Page No. - 43)

FIGURE 14 PEN NEEDLES MARKET, BY TYPE, 2023 VS. 2028 (USD MILLION)

FIGURE 15 PEN NEEDLES MARKET, BY LENGTH, 2023 VS. 2028 (USD MILLION)

FIGURE 16 PEN NEEDLES MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION)

FIGURE 17 PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2023 VS. 2028 (USD MILLION)

FIGURE 18 PEN NEEDLES MARKET, BY SETTING, 2023 VS. 2028 (USD MILLION)

FIGURE 19 GEOGRAPHIC GROWTH OPPORTUNITIES

4 PREMIUM INSIGHTS (Page No. - 47)

4.1 PEN NEEDLES MARKET OVERVIEW

FIGURE 20 RISING PREVALENCE OF CHRONIC DISEASES TO DRIVE MARKET GROWTH DURING FORECAST PERIOD

4.2 ASIA PACIFIC: PEN NEEDLES MARKET, BY LENGTH (2023)

FIGURE 21 5MM SEGMENT TO DOMINATE ASIA PACIFIC MARKET

4.3 GEOGRAPHIC GROWTH OPPORTUNITIES

FIGURE 22 EMERGING MARKETS TO GROW AT HIGHER CAGR DURING FORECAST PERIOD

4.4 REGIONAL MIX

FIGURE 23 NORTH AMERICA ACCOUNTED FOR LARGEST MARKET SHARE IN 2022

5 MARKET OVERVIEW (Page No. - 50)

5.1 INTRODUCTION

5.2 MARKET DYNAMICS

FIGURE 24 PEN NEEDLES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES

5.2.1 DRIVERS

5.2.1.1 Rising incidence of chronic diseases

FIGURE 25 NUMBER OF PEOPLE WITH CHRONIC CONDITIONS IN US, 1995–2030 (MILLION INDIVIDUALS)

FIGURE 26 TYPE 1 DIABETIC POPULATION, BY COUNTRY (2022)

5.2.1.2 Favorable reimbursements in mature markets

5.2.1.3 Growing adoption of self-administration

5.2.1.4 Decreasing prices of insulin formulations

5.2.2 RESTRAINTS

5.2.2.1 Alternative methods of drug delivery

5.2.2.2 Poor reimbursements in emerging markets

5.2.2.3 Needle anxiety

5.2.3 OPPORTUNITIES

5.2.3.1 Growing preference for biosimilar drugs

5.2.3.2 High-growth potential of emerging economies

5.2.3.3 Rising healthcare expenditure on diabetes

5.2.3.4 Regulatory mandates for safety pen needles

5.2.4 CHALLENGES

5.2.4.1 Reuse of pen needles

5.2.4.2 Misuse of injection pens

5.3 REIMBURSEMENT SCENARIO

TABLE 3 REIMBURSEMENT OF PEN NEEDLES, BY COUNTRY

5.4 PRICING ANALYSIS

5.4.1 AVERAGE SELLING PRICE FOR PEN NEEDLES, BY TYPE

TABLE 4 PRICING OF PEN NEEDLES, BY KEY PLAYERS

FIGURE 27 AVERAGE SELLING PRICE OF PEN NEEDLES, BY TYPE

5.4.2 AVERAGE SELLING PRICE TRENDS

5.5 VALUE CHAIN ANALYSIS

FIGURE 28 PEN NEEDLES MARKET: VALUE CHAIN ANALYSIS

5.6 ECOSYSTEM/MARKET MAP

FIGURE 29 PEN NEEDLES MARKET: ECOSYSTEM/MARKET MAP

5.7 PORTER’S FIVE FORCES ANALYSIS

TABLE 5 PEN NEEDLES MARKET: PORTER’S FIVE FORCES ANALYSIS

5.7.1 INTENSITY OF COMPETITIVE RIVALRY

5.7.2 BARGAINING POWER OF SUPPLIERS

5.7.3 BARGAINING POWER OF BUYERS

5.7.4 THREAT OF SUBSTITUTES

5.7.5 THREAT OF NEW ENTRANTS

5.8 SUPPLY CHAIN ANALYSIS

FIGURE 30 PEN NEEDLES MARKET: SUPPLY CHAIN ANALYSIS

5.9 REGULATORY ANALYSIS

5.9.1 NORTH AMERICA

5.9.1.1 US

TABLE 6 US FDA: MEDICAL DEVICE CLASSIFICATION

TABLE 7 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS

5.9.1.2 Canada

TABLE 8 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS

FIGURE 31 CANADA: CLASS II MEDICAL DEVICE APPROVAL PROCESS

5.9.2 EUROPE

FIGURE 32 EUROPE: CE APPROVAL PROCESS FOR CLASS IIA MEDICAL DEVICES

5.9.3 ASIA PACIFIC

5.9.3.1 Japan

TABLE 9 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA

5.9.3.2 China

TABLE 10 CHINA: REGULATORY BODIES APPOINTED FOR MEDICAL DEVICE APPROVAL

TABLE 11 CHINA: CLASSIFICATION OF MEDICAL DEVICES

5.9.3.3 India

5.9.4 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS

TABLE 12 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS

TABLE 13 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS

TABLE 14 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS

TABLE 15 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS

5.10 HS CODES: PEN INJECTORS

5.11 PATENT ANALYSIS

5.11.1 PATENT PUBLICATION TRENDS FOR PEN NEEDLES

FIGURE 33 PATENT PUBLICATION TRENDS (JANUARY 2013–SEPTEMBER 2023)

5.11.2 INSIGHTS: JURISDICTION AND TOP APPLICANTS ANALYSIS

FIGURE 34 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR PEN NEEDLE PATENTS (JANUARY 2013–SEPTEMBER 2023)

FIGURE 35 TOP APPLICANT COUNTRIES FOR PEN NEEDLE PATENTS (JANUARY 2013– SEPTEMBER 2023)

TABLE 16 PEN INJECTORS MARKET: MAJOR PATENTS

5.12 KEY STAKEHOLDERS AND BUYING CRITERIA

5.12.1 KEY STAKEHOLDERS IN BUYING PROCESS

FIGURE 36 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR PEN NEEDLES

TABLE 17 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR PEN NEEDLES

5.12.2 BUYING CRITERIA

FIGURE 37 KEY BUYING CRITERIA FOR PEN NEEDLES, BY TYPE

TABLE 18 KEY BUYING CRITERIA FOR PEN NEEDLES

5.13 CASE STUDY ANALYSIS

TABLE 19 CONTRIBUTION OF SMART INSULIN PENS FOR DIABETES MANAGEMENT

5.14 TECHNOLOGY ANALYSIS

5.14.1 KEY TECHNOLOGY

5.14.1.1 Fluid flow enhancement technology

5.14.2 COMPLEMENTARY TECHNOLOGY

5.14.2.1 Microfabricated needles

5.14.2.2 AI in pen injectors

5.14.3 ADJACENT TECHNOLOGY

5.14.3.1 Autoinjectors

5.15 KEY CONFERENCES AND EVENTS

TABLE 20 PEN NEEDLES MARKET: DETAILED LIST OF CONFERENCES AND EVENTS (2023−2024)

5.16 ADJACENT MARKETS ANALYSIS

FIGURE 38 PEN NEEDLES MARKET: ADJACENT MARKETS

5.17 USER REQUIREMENTS IN PEN NEEDLES MARKET

6 PEN NEEDLES MARKET, BY TYPE (Page No. - 84)

6.1 INTRODUCTION

TABLE 21 PEN NEEDLES MARKET, BY TYPE, 2021–2028 (USD MILLION)

TABLE 22 PEN NEEDLES MARKET, BY REGION, 2021–2028 (MILLION UNITS)

6.2 STANDARD PEN NEEDLES

6.2.1 GROWING PREFERENCE DUE TO LOW COSTS TO DRIVE MARKET

TABLE 23 STANDARD PEN NEEDLES OFFERED BY KEY PLAYERS

TABLE 24 STANDARD PEN NEEDLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)

TABLE 25 STANDARD PEN NEEDLES MARKET, BY REGION, 2021–2028 (MILLION UNITS)

6.3 SAFETY PEN NEEDLES

6.3.1 CONCERNS ASSOCIATED WITH NEEDLESTICK INJURIES TO PROPEL MARKET

TABLE 26 SAFETY PEN NEEDLES OFFERED BY KEY PLAYERS

TABLE 27 SAFETY PEN NEEDLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)

TABLE 28 SAFETY PEN NEEDLES MARKET, BY REGION, 2021–2028 (MILLION UNITS)

7 PEN NEEDLES MARKET, BY LENGTH (Page No. - 90)

7.1 INTRODUCTION

TABLE 29 PEN NEEDLES MARKET, BY LENGTH, 2021–2028 (USD MILLION)

7.2 8MM

7.2.1 WIDE ADOPTION IN NORTH AMERICA TO BOOST DEMAND

TABLE 30 8MM PEN NEEDLES OFFERED BY KEY PLAYERS

TABLE 31 8MM PEN NEEDLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)

7.3 5MM

7.3.1 SHORTER LENGTH TO FUEL UPTAKE

TABLE 32 5MM PEN NEEDLES OFFERED BY KEY PLAYERS

TABLE 33 5MM PEN NEEDLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)

7.4 6MM

7.4.1 FAVORABLE REIMBURSEMENTS TO BOOST DEMAND

TABLE 34 6MM PEN NEEDLES OFFERED BY KEY PLAYERS

TABLE 35 6MM PEN NEEDLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)

7.5 4MM

7.5.1 WIDE ADOPTION AMONG CHILDREN FOR INSULIN DELIVERY TO DRIVE DEMAND

TABLE 36 4MM PEN NEEDLES OFFERED BY KEY PLAYERS

TABLE 37 4MM PEN NEEDLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)

7.6 12MM

7.6.1 HIGH UTILIZATION OF SHORTER NEEDLES TO LIMIT ADOPTION

TABLE 38 12MM PEN NEEDLES OFFERED BY KEY PLAYERS

TABLE 39 12MM PEN NEEDLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)

7.7 10MM

7.7.1 PAINFUL ADMINISTRATION TO RESTRAIN ADOPTION

TABLE 40 10MM PEN NEEDLES OFFERED BY KEY PLAYERS

TABLE 41 10MM PEN NEEDLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)

8 PEN NEEDLES MARKET, BY APPLICATION (Page No. - 101)

8.1 INTRODUCTION

TABLE 42 PEN NEEDLES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)

8.2 INSULIN THERAPY

8.2.1 RISING INCIDENCE OF DIABETES TO PROPEL MARKET

TABLE 43 PEN NEEDLES MARKET FOR INSULIN THERAPY, BY COUNTRY, 2021–2028 (USD MILLION)

8.3 GLUCAGON-LIKE PEPTIDE-1 THERAPY (GLP-1 THERAPY)

8.3.1 GROWING FOCUS OF PHARMA COMPANIES ON GLP-1-BASED THERAPIES TO DRIVE MARKET

TABLE 44 PEN NEEDLES MARKET FOR GLP-1 THERAPY, BY COUNTRY, 2021–2028 (USD MILLION)

8.4 GROWTH HORMONE THERAPY

8.4.1 RECURRING REQUIREMENT OF INJECTIONS TO RESTRAIN MARKET

TABLE 45 PEN NEEDLES MARKET FOR GROWTH HORMONE THERAPY, BY COUNTRY, 2021–2028 (USD MILLION)

8.5 OSTEOPOROSIS

8.5.1 RISING VITAMIN D DEFICIENCY CASES TO PROPEL MARKET

TABLE 46 PEN NEEDLES MARKET FOR OSTEOPOROSIS, BY COUNTRY, 2021–2028 (USD MILLION)

8.6 OTHER APPLICATIONS

TABLE 47 PEN NEEDLES MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)

9 PEN NEEDLES MARKET, BY SETTING (Page No. - 109)

9.1 INTRODUCTION

TABLE 48 PEN NEEDLES MARKET, BY SETTING, 2021–2028 (USD MILLION)

9.2 HOME CARE SETTINGS

9.2.1 GROWING PREFERENCE FOR SELF-ADMINISTRATION OF INSULIN TO PROPEL MARKET

TABLE 49 PEN NEEDLES MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2021–2028 (USD MILLION)

9.3 HOSPITALS AND CLINICS

9.3.1 INCREASING ADOPTION OF SAFETY PEN NEEDLES TO DRIVE MARKET

TABLE 50 PEN NEEDLES MARKET FOR HOSPITALS AND CLINICS, BY COUNTRY, 2021–2028 (USD MILLION)

9.4 OTHER SETTINGS

TABLE 51 PEN NEEDLES MARKET FOR OTHER SETTINGS, BY COUNTRY, 2021–2028 (USD MILLION)

10 PEN NEEDLES MARKET, BY MODE OF PURCHASE (Page No. - 114)

10.1 INTRODUCTION

TABLE 52 PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2021–2028 (USD MILLION)

10.2 PRESCRIPTION-BASED PURCHASE

10.2.1 RETAIL PURCHASES TO SUPPORT MARKET GROWTH

TABLE 53 PEN NEEDLES MARKET FOR PRESCRIPTION-BASED PURCHASE, BY COUNTRY, 2021–2028 (USD MILLION)

10.3 OVER-THE-COUNTER PURCHASE

10.3.1 DISCOUNTS OFFERED BY LOCAL PHARMACIES, SUPPLIERS, AND DISTRIBUTORS TO DRIVE MARKET

TABLE 54 PEN NEEDLES MARKET FOR OVER-THE-COUNTER PURCHASE, BY COUNTRY, 2021–2028 (USD MILLION)

10.4 ONLINE PURCHASE

10.4.1 CONVENIENT TIME-EFFICIENT BENEFITS TO PROPEL MARKET

TABLE 55 PEN NEEDLES MARKET FOR ONLINE PURCHASES, BY COUNTRY, 2021–2028 (USD MILLION)

10.5 OTHER MODES OF PURCHASE

TABLE 56 PEN NEEDLES MARKET FOR OTHER MODES OF PURCHASE, BY COUNTRY, 2021–2028 (USD MILLION)

11 PEN NEEDLES MARKET, BY REGION (Page No. - 121)

11.1 INTRODUCTION

TABLE 57 PEN NEEDLES MARKET, BY REGION, 2021–2028 (USD MILLION)

FIGURE 39 EMERGING MARKETS TO GROW AT HIGHER GROWTH RATE DURING FORECAST PERIOD

11.2 NORTH AMERICA

FIGURE 40 NORTH AMERICA: PEN NEEDLES MARKET SNAPSHOT

TABLE 58 NORTH AMERICA: PEN NEEDLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)

TABLE 59 NORTH AMERICA: PEN NEEDLES MARKET, BY TYPE, 2021–2028 (USD MILLION)

TABLE 60 NORTH AMERICA: PEN NEEDLES MARKET, BY LENGTH, 2021–2028 (USD MILLION)

TABLE 61 NORTH AMERICA: PEN NEEDLES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)

TABLE 62 NORTH AMERICA: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2021–2028 (USD MILLION)

TABLE 63 NORTH AMERICA: PEN NEEDLES MARKET, BY SETTING, 2021–2028 (USD MILLION)

11.2.1 US

11.2.1.1 Favorable reimbursements to propel market

FIGURE 41 TOTAL FERTILITY RATE IN US POPULATION (1990−2021)

TABLE 64 US: MACROECONOMIC INDICATORS

TABLE 65 US: PEN NEEDLES MARKET, BY TYPE, 2021–2028 (USD MILLION)

TABLE 66 US: PEN NEEDLES MARKET, BY LENGTH, 2021–2028 (USD MILLION)

TABLE 67 US: PEN NEEDLES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)

TABLE 68 US: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2021–2028 (USD MILLION)

TABLE 69 US: PEN NEEDLES MARKET, BY SETTING, 2021–2028 (USD MILLION)

11.2.2 CANADA

11.2.2.1 Rising prevalence of diabetes to drive market

TABLE 70 CANADA: MACROECONOMIC INDICATORS

TABLE 71 CANADA: PEN NEEDLES MARKET, BY TYPE, 2021–2028 (USD MILLION)

TABLE 72 CANADA: PEN NEEDLES MARKET, BY LENGTH, 2021–2028 (USD MILLION)

TABLE 73 CANADA: PEN NEEDLES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)

TABLE 74 CANADA: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2021–2028 (USD MILLION)

TABLE 75 CANADA: PEN NEEDLES MARKET, BY SETTING, 2021–2028 (USD MILLION)

11.2.3 NORTH AMERICA: RECESSION IMPACT

11.3 EUROPE

TABLE 76 EUROPE: PEN NEEDLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)

TABLE 77 EUROPE: PEN NEEDLES MARKET, BY TYPE, 2021–2028 (USD MILLION)

TABLE 78 EUROPE: PEN NEEDLES MARKET, BY LENGTH, 2021–2028 (USD MILLION)

TABLE 79 EUROPE: PEN NEEDLES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)

TABLE 80 EUROPE: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2021–2028 (USD MILLION)

TABLE 81 EUROPE: PEN NEEDLES MARKET, BY SETTING, 2021–2028 (USD MILLION)

11.3.1 GERMANY

11.3.1.1 High healthcare spending to propel market

TABLE 82 GERMANY: MACROECONOMIC INDICATORS

TABLE 83 GERMANY: PEN NEEDLES MARKET, BY TYPE, 2021–2028 (USD MILLION)

TABLE 84 GERMANY: PEN NEEDLES MARKET, BY LENGTH, 2021–2028 (USD MILLION)

TABLE 85 GERMANY: PEN NEEDLES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)

TABLE 86 GERMANY: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2021–2028 (USD MILLION)

TABLE 87 GERMANY: PEN NEEDLES MARKET, BY SETTING, 2021–2028 (USD MILLION)

11.3.2 UK

11.3.2.1 NHS support and growing access to cost-effective pen needles to drive market

TABLE 88 UK: MACROECONOMIC INDICATORS

TABLE 89 UK: PEN NEEDLES MARKET, BY TYPE, 2021–2028 (USD MILLION)

TABLE 90 UK: PEN NEEDLES MARKET, BY LENGTH, 2021–2028 (USD MILLION)

TABLE 91 UK: PEN NEEDLES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)

TABLE 92 UK: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2021–2028 (USD MILLION)

TABLE 93 UK: PEN NEEDLES MARKET, BY SETTING, 2021–2028 (USD MILLION)

11.3.3 FRANCE

11.3.3.1 Favorable health insurance system to propel market

TABLE 94 FRANCE: MACROECONOMIC INDICATORS

TABLE 95 FRANCE: PEN NEEDLES MARKET, BY TYPE, 2021–2028 (USD MILLION)

TABLE 96 FRANCE: PEN NEEDLES MARKET, BY LENGTH, 2021–2028 (USD MILLION)

TABLE 97 FRANCE: PEN NEEDLES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)

TABLE 98 FRANCE: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2021–2028 (USD MILLION)

TABLE 99 FRANCE: PEN NEEDLES MARKET, BY SETTING, 2021–2028 (USD MILLION)

11.3.4 ITALY

11.3.4.1 Low product pricing to support market growth

TABLE 100 ITALY: MACROECONOMIC INDICATORS

TABLE 101 ITALY: PEN NEEDLES MARKET, BY TYPE, 2021–2028 (USD MILLION)

TABLE 102 ITALY: PEN NEEDLES MARKET, BY LENGTH, 2021–2028 (USD MILLION)

TABLE 103 ITALY: PEN NEEDLES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)

TABLE 104 ITALY: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2021–2028 (USD MILLION)

TABLE 105 ITALY: PEN NEEDLES MARKET, BY SETTING, 2021–2028 (USD MILLION)

11.3.5 SPAIN

11.3.5.1 Supportive regulations mandating the use of safety pen needles to propel market

TABLE 106 SPAIN: MACROECONOMIC INDICATORS

TABLE 107 SPAIN: PEN NEEDLES MARKET, BY TYPE, 2021–2028 (USD MILLION)

TABLE 108 SPAIN: PEN NEEDLES MARKET, BY LENGTH, 2021–2028 (USD MILLION)

TABLE 109 SPAIN: PEN NEEDLES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)

TABLE 110 SPAIN: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2021–2028 (USD MILLION)

TABLE 111 SPAIN: PEN NEEDLES MARKET, BY SETTING, 2021–2028 (USD MILLION)

11.3.6 REST OF EUROPE

TABLE 112 REST OF EUROPE: PEN NEEDLES MARKET, BY TYPE, 2021–2028 (USD MILLION)

TABLE 113 REST OF EUROPE: PEN NEEDLES MARKET, BY LENGTH, 2021–2028 (USD MILLION)

TABLE 114 REST OF EUROPE: PEN NEEDLES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)

TABLE 115 REST OF EUROPE: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2021–2028 (USD MILLION)

TABLE 116 REST OF EUROPE: PEN NEEDLES MARKET, BY SETTING, 2021–2028 (USD MILLION)

11.3.7 EUROPE: RECESSION IMPACT

11.4 ASIA PACIFIC

FIGURE 42 ASIA PACIFIC: PEN NEEDLES MARKET SNAPSHOT

TABLE 117 ASIA PACIFIC: PEN NEEDLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)

TABLE 118 ASIA PACIFIC: PEN NEEDLES MARKET, BY TYPE, 2021–2028 (USD MILLION)

TABLE 119 ASIA PACIFIC: PEN NEEDLES MARKET, BY LENGTH, 2021–2028 (USD MILLION)

TABLE 120 ASIA PACIFIC: PEN NEEDLES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)

TABLE 121 ASIA PACIFIC: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2021–2028 (USD MILLION)

TABLE 122 ASIA PACIFIC: PEN NEEDLES MARKET, BY SETTING, 2021–2028 (USD MILLION)

11.4.1 JAPAN

11.4.1.1 Supportive reimbursement policies and universal healthcare coverage to propel market

TABLE 123 JAPAN: MACROECONOMIC INDICATORS

TABLE 124 JAPAN: PEN NEEDLES MARKET, BY TYPE, 2021–2028 (USD MILLION)

TABLE 125 JAPAN: PEN NEEDLES MARKET, BY LENGTH, 2021–2028 (USD MILLION)

TABLE 126 JAPAN: PEN NEEDLES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)

TABLE 127 JAPAN: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2021–2028 (USD MILLION)

TABLE 128 JAPAN: PEN NEEDLES MARKET, BY SETTING, 2021–2028 (USD MILLION)

11.4.2 CHINA

11.4.2.1 Large patient population and healthcare infrastructure improvements to drive market growth

TABLE 129 CHINA: MACROECONOMIC INDICATORS

TABLE 130 CHINA: PEN NEEDLES MARKET, BY TYPE, 2021–2028 (USD MILLION)

TABLE 131 CHINA: PEN NEEDLES MARKET, BY LENGTH, 2021–2028 (USD MILLION)

TABLE 132 CHINA: PEN NEEDLES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)

TABLE 133 CHINA: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2021–2028 (USD MILLION)

TABLE 134 CHINA: PEN NEEDLES MARKET, BY SETTING, 2021–2028 (USD MILLION)

11.4.3 AUSTRALIA & NEW ZEALAND

11.4.3.1 High healthcare expenditure to support market growth

TABLE 135 AUSTRALIA & NEW ZEALAND: PEN NEEDLES MARKET, BY TYPE, 2021–2028 (USD MILLION)

TABLE 136 AUSTRALIA & NEW ZEALAND: PEN NEEDLES MARKET, BY LENGTH, 2021–2028 (USD MILLION)

TABLE 137 AUSTRALIA & NEW ZEALAND: PEN NEEDLES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)

TABLE 138 AUSTRALIA & NEW ZEALAND: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2021–2028 (USD MILLION)

TABLE 139 AUSTRALIA & NEW ZEALAND: PEN NEEDLES MARKET, BY SETTING, 2021–2028 (USD MILLION)

11.4.4 INDIA

11.4.4.1 Healthcare infrastructural improvements and rising disease burden to propel market

TABLE 140 INDIA: MACROECONOMIC INDICATORS

TABLE 141 INDIA: PEN NEEDLES MARKET, BY TYPE, 2021–2028 (USD MILLION)

TABLE 142 INDIA: PEN NEEDLES MARKET, BY LENGTH, 2021–2028 (USD MILLION)

TABLE 143 INDIA: PEN NEEDLES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)

TABLE 144 INDIA: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2021–2028 (USD MILLION)

TABLE 145 INDIA: PEN NEEDLES MARKET, BY SETTING, 2021–2028 (USD MILLION)

11.4.5 SOUTH KOREA

11.4.5.1 Rising incidence of obesity and hypertension to support market growth

TABLE 146 SOUTH KOREA: MACROECONOMIC INDICATORS

TABLE 147 SOUTH KOREA: PEN NEEDLES MARKET, BY TYPE, 2021–2028 (USD MILLION)

TABLE 148 SOUTH KOREA: PEN NEEDLES MARKET, BY LENGTH, 2021–2028 (USD MILLION)

TABLE 149 SOUTH KOREA: PEN NEEDLES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)

TABLE 150 SOUTH KOREA: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2021–2028 (USD MILLION)

TABLE 151 SOUTH KOREA: PEN NEEDLES MARKET, BY SETTING, 2021–2028 (USD MILLION)

11.4.6 SOUTHEAST ASIA

11.4.6.1 Growing awareness about diabetes to propel market

FIGURE 43 PREVALENCE OF DIABETES IN SOUTHEAST ASIA (2021 VS. 2030)

FIGURE 44 HEALTHCARE EXPENDITURE (% GDP) IN SOUTHEAST ASIA (2020)

FIGURE 45 ELDERLY POPULATION IN SOUTHEAST ASIA (2022)

TABLE 152 SOUTHEAST ASIA: PEN NEEDLES MARKET, BY TYPE, 2021–2028 (USD MILLION)

TABLE 153 SOUTHEAST ASIA: PEN NEEDLES MARKET, BY LENGTH, 2021–2028 (USD MILLION)

TABLE 154 SOUTHEAST ASIA: PEN NEEDLES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)

TABLE 155 SOUTHEAST ASIA: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2021–2028 (USD MILLION)

TABLE 156 SOUTHEAST ASIA: PEN NEEDLES MARKET, BY SETTING, 2021–2028 (USD MILLION)

11.4.7 REST OF ASIA PACIFIC

TABLE 157 REST OF ASIA PACIFIC: PEN NEEDLES MARKET, BY TYPE, 2021–2028 (USD MILLION)

TABLE 158 REST OF ASIA PACIFIC: PEN NEEDLES MARKET, BY LENGTH, 2021–2028 (USD MILLION)

TABLE 159 REST OF ASIA PACIFIC: PEN NEEDLES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)

TABLE 160 REST OF ASIA PACIFIC: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2021–2028 (USD MILLION)

TABLE 161 REST OF ASIA PACIFIC: PEN NEEDLES MARKET, BY SETTING, 2021–2028 (USD MILLION)

11.4.8 ASIA PACIFIC: RECESSION IMPACT

11.5 LATIN AMERICA

TABLE 162 LATIN AMERICA: PEN NEEDLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)

TABLE 163 LATIN AMERICA: PEN NEEDLES MARKET, BY TYPE, 2021–2028 (USD MILLION)

TABLE 164 LATIN AMERICA: PEN NEEDLES MARKET, BY LENGTH, 2021–2028 (USD MILLION)

TABLE 165 LATIN AMERICA: PEN NEEDLES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)

TABLE 166 LATIN AMERICA: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2021–2028 (USD MILLION)

TABLE 167 LATIN AMERICA: PEN NEEDLES MARKET, BY SETTING, 2021–2028 (USD MILLION)

11.5.1 BRAZIL

11.5.1.1 Growing adoption of safety pen needles to drive market

TABLE 168 BRAZIL: MACROECONOMIC INDICATORS

TABLE 169 BRAZIL: PEN NEEDLES MARKET, BY TYPE, 2021–2028 (USD MILLION)

TABLE 170 BRAZIL: PEN NEEDLES MARKET, BY LENGTH, 2021–2028 (USD MILLION)

TABLE 171 BRAZIL: PEN NEEDLES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)

TABLE 172 BRAZIL: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2021–2028 (USD MILLION)

TABLE 173 BRAZIL: PEN NEEDLES MARKET, BY SETTING, 2021–2028 (USD MILLION)

11.5.2 MEXICO

11.5.2.1 Low coverage for core health services to restrain market

TABLE 174 MEXICO: MACROECONOMIC INDICATORS

TABLE 175 MEXICO: PEN NEEDLES MARKET, BY TYPE, 2021–2028 (USD MILLION)

TABLE 176 MEXICO: PEN NEEDLES MARKET, BY LENGTH, 2021–2028 (USD MILLION)

TABLE 177 MEXICO: PEN NEEDLES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)

TABLE 178 MEXICO: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2021–2028 (USD MILLION)

TABLE 179 MEXICO: PEN NEEDLES MARKET, BY SETTING, 2021–2028 (USD MILLION)

11.5.3 ARGENTINA

11.5.3.1 High out-of-pocket expenditure on insulin products to restrain market

TABLE 180 ARGENTINA: MACROECONOMIC INDICATORS

TABLE 181 ARGENTINA: PEN NEEDLES MARKET, BY TYPE, 2021–2028 (USD MILLION)

TABLE 182 ARGENTINA: PEN NEEDLES MARKET, BY LENGTH, 2021–2028 (USD MILLION)

TABLE 183 ARGENTINA: PEN NEEDLES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)

TABLE 184 ARGENTINA: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2021–2028 (USD MILLION)

TABLE 185 ARGENTINA: PEN NEEDLES MARKET, BY SETTING, 2021–2028 (USD MILLION)

11.5.4 REST OF LATIN AMERICA

FIGURE 46 HEALTH EXPENDITURE OF COUNTRIES IN LATIN AMERICA FOR 2020 (% GDP)

TABLE 186 REST OF LATIN AMERICA: PEN NEEDLES MARKET, BY TYPE, 2021–2028 (USD MILLION)

TABLE 187 REST OF LATIN AMERICA: PEN NEEDLES MARKET, BY LENGTH, 2021–2028 (USD MILLION)

TABLE 188 REST OF LATIN AMERICA: PEN NEEDLES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)

TABLE 189 REST OF LATIN AMERICA: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2021–2028 (USD MILLION)

TABLE 190 REST OF LATIN AMERICA: PEN NEEDLES MARKET, BY SETTING, 2021–2028 (USD MILLION)

11.5.5 LATIN AMERICA: RECESSION IMPACT

11.6 MIDDLE EAST & AFRICA

11.6.1 INITIATIVES TO ENHANCE HEALTHCARE ACCESSIBILITY TO SUPPORT MARKET GROWTH

11.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT

TABLE 191 MIDDLE EAST & AFRICA: PEN NEEDLES MARKET, BY TYPE, 2021–2028 (USD MILLION)

TABLE 192 MIDDLE EAST & AFRICA: PEN NEEDLES MARKET, BY LENGTH, 2021–2028 (USD MILLION)

TABLE 193 MIDDLE EAST & AFRICA: PEN NEEDLES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)

TABLE 194 MIDDLE EAST & AFRICA: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2021–2028 (USD MILLION)

TABLE 195 MIDDLE EAST & AFRICA: PEN NEEDLES MARKET, BY SETTING, 2021–2028 (USD MILLION)

12 COMPETITIVE LANDSCAPE (Page No. - 187)

12.1 OVERVIEW

12.2 KEY PLAYER STRATEGIES

TABLE 196 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN PEN NEEDLES MARKET

12.3 REVENUE SHARE ANALYSIS

FIGURE 47 REVENUE ANALYSIS FOR KEY COMPANIES IN LAST FIVE YEARS

12.4 MARKET SHARE ANALYSIS

FIGURE 48 PEN NEEDLES MARKET SHARE, BY KEY PLAYER (2022)

12.5 COMPANY EVALUATION MATRIX (2022)

12.5.1 STARS

12.5.2 EMERGING LEADERS

12.5.3 PERVASIVE PLAYERS

12.5.4 PARTICIPANTS

FIGURE 49 PEN NEEDLES MARKET: COMPANY EVALUATION MATRIX (2022)

12.5.5 COMPANY FOOTPRINT

TABLE 197 PEN NEEDLES MARKET: OVERALL COMPANY FOOTPRINT (20 COMPANIES)

TABLE 198 PEN NEEDLES MARKET: TYPE FOOTPRINT (20 COMPANIES)

TABLE 199 PEN NEEDLES MARKET: LENGTH FOOTPRINT (20 COMPANIES)

TABLE 200 PEN NEEDLES MARKET: APPLICATION FOOTPRINT (20 COMPANIES)

TABLE 201 PEN NEEDLES MARKET: REGIONAL FOOTPRINT (20 COMPANIES)

12.6 START-UP/SME EVALUATION MATRIX (2022)

12.6.1 PROGRESSIVE COMPANIES

12.6.2 RESPONSIVE COMPANIES

12.6.3 DYNAMIC COMPANIES

12.6.4 STARTING BLOCKS

FIGURE 50 PEN NEEDLES MARKET: COMPANY EVALUATION MATRIX FOR START-UPS (2022)

12.6.5 COMPETITIVE BENCHMARKING

TABLE 202 PEN NEEDLES MARKET: DETAILED LIST OF KEY START-UPS/SMES

12.7 COMPETITIVE SCENARIOS AND TRENDS

12.7.1 PRODUCT LAUNCHES

TABLE 203 PEN NEEDLES MARKET: PRODUCT LAUNCHES & APPROVALS (JANUARY 2020–OCTOBER 2023)

12.7.2 DEALS

TABLE 204 PEN NEEDLES MARKET: DEALS (JANUARY 2020– OCTOBER 2023)

12.7.3 OTHER DEVELOPMENTS

TABLE 205 PEN NEEDLES MARKET: OTHER DEVELOPMENTS (JANUARY 2020– OCTOBER 2023)

13 COMPANY PROFILES (Page No. - 202)

(Business overview, Products offered, Recent developments & MnM View)*

13.1 KEY PLAYERS

13.1.1 EMBECTA CORP. (PART OF BD)

TABLE 206 EMBECTA CORP.: COMPANY OVERVIEW

FIGURE 51 EMBECTA CORP.: COMPANY SNAPSHOT (2022)

13.1.2 NOVO NORDISK A/S

TABLE 207 NOVO NORDISK A/S: COMPANY OVERVIEW

FIGURE 52 NOVO NORDISK A/S: COMPANY SNAPSHOT (2022)

13.1.3 YPSOMED AG

TABLE 208 YPSOMED AG: COMPANY OVERVIEW

FIGURE 53 YPSOMED AG: COMPANY SNAPSHOT (2022)

13.1.4 B. BRAUN MELSUNGEN AG

TABLE 209 B. BRAUN MELSUNGEN AG: COMPANY OVERVIEW

FIGURE 54 B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT (2022)

13.1.5 TERUMO CORPORATION

TABLE 210 TERUMO CORPORATION: COMPANY OVERVIEW

FIGURE 55 TERUMO CORPORATION: COMPANY SNAPSHOT (2022)

13.1.6 NIPRO CORPORATION

TABLE 211 NIPRO CORPORATION: COMPANY OVERVIEW

FIGURE 56 NIPRO CORPORATION: COMPANY SNAPSHOT (2022)

13.1.7 OWEN MUMFORD

TABLE 212 OWEN MUMFORD: BUSINESS OVERVIEW

13.1.8 ARKRAY, INC.

TABLE 213 ARKRAY: BUSINESS OVERVIEW

13.1.9 ULTIMED, INC.

TABLE 214 ULTIMED, INC.: BUSINESS OVERVIEW

13.1.10 HINDUSTAN SYRINGES & MEDICAL DEVICES LTD.

TABLE 215 HINDUSTAN SYRINGES & MEDICAL DEVICES LTD.: BUSINESS OVERVIEW

13.1.11 MONTMED, INC.

TABLE 216 MONTMED, INC.: BUSINESS OVERVIEW

13.1.12 HTL-STREFA

TABLE 217 HTL-STREFA: BUSINESS OVERVIEW

13.1.13 ALLISON MEDICAL, INC.

TABLE 218 ALLISON MEDICAL, INC.: BUSINESS OVERVIEW

13.1.14 GLUCORX LIMITED

TABLE 219 GLUCORX LIMITED: BUSINESS OVERVIEW

13.1.15 BERPU MEDICAL TECHNOLOGY CO., LTD.

TABLE 220 BERPU MEDICAL TECHNOLOGY CO., LTD.: BUSINESS OVERVIEW

13.1.16 ADVACARE PHARMA

TABLE 221 ADVACARE PHARMA: BUSINESS OVERVIEW

13.1.17 ARTSANA GROUP

TABLE 222 ARTSANA GROUP: BUSINESS OVERVIEW

13.1.18 PROMISEMED MEDICAL DEVICES INC.

TABLE 223 PROMISEMED MEDICAL DEVICES INC.: BUSINESS OVERVIEW

13.1.19 TRIVIDIA HEALTH, INC.

TABLE 224 TRIVIDIA HEALTH, INC.: BUSINESS OVERVIEW

13.1.20 VOGT MEDICAL VERTRIEB GMBH

TABLE 225 VOGT MEDICAL VERTRIEB GMBH: BUSINESS OVERVIEW

*Details on Business overview, Products offered, Recent developments & MnM View might not be captured in case of unlisted companies.

13.2 OTHER PLAYERS

13.2.1 VAN HEEK MEDICAL

TABLE 226 VAN HEEK MEDICAL: COMPANY OVERVIEW

13.2.2 SIMPLE DIAGNOSTICS

TABLE 227 SIMPLE DIAGNOSTICS: COMPANY OVERVIEW

13.2.3 IYON MEDICAL

TABLE 228 IYON MEDICAL: COMPANY OVERVIEW

13.2.4 LINKS MEDICAL PRODUCTS, INC.

TABLE 229 LINKS MEDICAL PRODUCTS, INC.: COMPANY OVERVIEW

13.2.5 MHC MEDICAL PRODUCTS, LLC

TABLE 230 MHC MEDICAL PRODUCTS: COMPANY OVERVIEW

14 APPENDIX (Page No. - 241)

14.1 DISCUSSION GUIDE

14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL

14.3 CUSTOMIZATION OPTIONS

14.4 RELATED REPORTS

14.5 AUTHOR DETAILS

The study involved four major activities to estimate the current size of the Pen Needles market. Exhaustive secondary research was carried out to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation procedures were used to estimate the size of segments and subsegments.

Secondary Research

In the secondary research process, various secondary sources, such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, regulatory bodies, and publications from government sources [such as National Institutes of Health (NIH), US FDA, US Census Bureau, World Health Organization (WHO), American Diabetes Association (ADA), American Association of Diabetes Educators (AADE), European Association for the Study of Diabetes] were referred to identify and collect information for the pen needles market study.

Primary Research

The pen needles market comprises several stakeholders such as manufacturers of pen needles, insulin pens, injectable drug delivery devices, and diabetes supplies, original equipment manufacturing companies, suppliers and distributors of pen needles, insulin pens, injectable drug delivery devices, and diabetes supplies, healthcare service providers, teaching hospitals and academic medical centers, health insurance players, government bodies/municipal corporations, regulatory bodies, business research and consulting service providers, authorities framing reimbursement policies for pen needles, venture capitalists, and market research and consulting firms.

Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information. The following is the breakdown of primary respondents:

Pen Needles Market Size, and Share

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the total size of the pen needles market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

The key players in the industry and markets have been identified through extensive secondary research
The industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research
All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources

Demand-Side Analysis (Bottom-Up Approach)

Pen Needles Market Size, and Share

To know about the assumptions considered for the study, Request for Free Sample Report

Top-Down Approach

Pen Needles Market Size, and Share

Data Triangulation

After arriving at the market size, the total market was divided into several segments and sub-segments. To complete the overall market engineering process and arrive at the exact statistics for all segments and sub-segments, data triangulation and market breakdown procedures were employed, wherever applicable. The following figure shows the market validation, source structure, and data triangulation methodology implemented in the market engineering process.

Market Definition

A pen needle is a hollow needle entrenched in a plastic hub and attached to injectable pens. Pen needles are available in a wide range of lengths and diameters and can be used by healthcare professionals and patients to deliver injectable medications into the patient’s body. Pen needles are electro-polished for smooth, thin, and fine-point tips and provide comfort and ease in penetration; they serve as an alternative drug delivery technique to the traditional method of injecting drugs.

Key stakeholders

Manufacturers of pen needles, insulin pens, injectable drug delivery devices, and diabetes supplies
Original equipment manufacturing companies
Suppliers and distributors of pen needles, insulin pens, injectable drug delivery devices, and diabetes supplies
Healthcare service providers
Teaching hospitals and academic medical centers
Health insurance players
Government bodies/municipal corporations
Regulatory bodies
Business research and consulting service providers
Authorities framing reimbursement policies for pen needles
Venture capitalists
Market research and consulting firms

Report Objectives

To define, describe, and forecast the global pen needles market on the basis of length, application, type, setting, mode of purchase, and region.
To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
To strategically analyze micromarkets1 with respect to individual growth trends, future prospects, and contributions to the overall market
To analyze the opportunities in the market for key stakeholders and provide details of the competitive landscape for major market leaders
To forecast the size of the market segments with respect to five main regions, namely, North America (the US and Canada), Europe (Germany, the UK, France, Italy, Spain, and Rest of Europe), Asia Pacific (Japan, China, India, Australia, South Korea, Southeast Asia, and Rest of Asia Pacific), Latin America (Brazil, Mexico, Argentina, and Rest of Latin America), and the Middle East & Africa
To profile the key market players and comprehensively analyze their market shares and core competencies2
To track and analyze competitive developments such as partnerships, agreements, collaborations, and expansions in the global pen needles market

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per your company’s specific needs. The following customization options are available for the global pen needles market report

Geographic Analysis

Further breakdown of the RoE pen needles market into Belgium, Russia, the Netherlands, Switzerland, and others.
Further breakdown of the RoAPAC pen needles market
Further breakdown of the RoLA pen needles market

Portfolio Assessment

Product Matrix, which gives a detailed comparison of the product portfolios of the top three companies

Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.